| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Repair | 115 | 2023 | 1872 | 7.320 |
Why?
|
| DNA-Directed DNA Polymerase | 37 | 2023 | 182 | 4.830 |
Why?
|
| DNA Damage | 64 | 2022 | 1954 | 3.300 |
Why?
|
| Xeroderma Pigmentosum | 38 | 2007 | 70 | 3.040 |
Why?
|
| Endonucleases | 28 | 2009 | 178 | 2.510 |
Why?
|
| DNA | 47 | 2023 | 2693 | 2.120 |
Why?
|
| DNA-Binding Proteins | 56 | 2018 | 4821 | 1.990 |
Why?
|
| Ultraviolet Rays | 51 | 2009 | 575 | 1.830 |
Why?
|
| Vitamin D | 3 | 2020 | 261 | 1.830 |
Why?
|
| Proteins | 22 | 2018 | 1963 | 1.300 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 16 | 2018 | 46 | 1.110 |
Why?
|
| DNA Replication | 25 | 2012 | 744 | 1.000 |
Why?
|
| DNA End-Joining Repair | 3 | 2023 | 86 | 0.960 |
Why?
|
| Sulfoxides | 2 | 2020 | 22 | 0.960 |
Why?
|
| Isothiocyanates | 2 | 2020 | 44 | 0.930 |
Why?
|
| Molecular Biology | 1 | 2023 | 176 | 0.840 |
Why?
|
| Vitamins | 4 | 2019 | 157 | 0.830 |
Why?
|
| DNA, Neoplasm | 2 | 2018 | 1910 | 0.800 |
Why?
|
| Histone Deacetylases | 2 | 2020 | 365 | 0.790 |
Why?
|
| DNA Polymerase I | 5 | 2006 | 27 | 0.770 |
Why?
|
| Plasmids | 20 | 2006 | 837 | 0.730 |
Why?
|
| DNA, Circular | 7 | 2006 | 34 | 0.730 |
Why?
|
| Calcitriol | 5 | 2009 | 127 | 0.720 |
Why?
|
| Escherichia coli Proteins | 9 | 2001 | 359 | 0.710 |
Why?
|
| Hirschsprung Disease | 1 | 2019 | 46 | 0.700 |
Why?
|
| Enterocolitis | 1 | 2019 | 43 | 0.690 |
Why?
|
| Cisplatin | 17 | 2008 | 2432 | 0.680 |
Why?
|
| Cockayne Syndrome | 9 | 2007 | 24 | 0.670 |
Why?
|
| Mad2 Proteins | 2 | 2018 | 33 | 0.660 |
Why?
|
| Molecular Sequence Data | 35 | 2010 | 6089 | 0.660 |
Why?
|
| Thymine | 5 | 2010 | 46 | 0.660 |
Why?
|
| Vitamin D Deficiency | 1 | 2019 | 115 | 0.620 |
Why?
|
| Cross-Linking Reagents | 7 | 2010 | 153 | 0.610 |
Why?
|
| Pyrimidine Dimers | 12 | 2006 | 23 | 0.600 |
Why?
|
| Cell Extracts | 15 | 2006 | 62 | 0.600 |
Why?
|
| Iron | 5 | 2012 | 376 | 0.580 |
Why?
|
| Down Syndrome | 1 | 2019 | 226 | 0.580 |
Why?
|
| DNA Helicases | 9 | 2006 | 434 | 0.560 |
Why?
|
| Caco-2 Cells | 5 | 2020 | 158 | 0.550 |
Why?
|
| Enterocytes | 2 | 2008 | 68 | 0.540 |
Why?
|
| Recombinational DNA Repair | 1 | 2016 | 79 | 0.540 |
Why?
|
| Dietary Supplements | 3 | 2019 | 558 | 0.530 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 493 | 0.510 |
Why?
|
| Escherichia coli | 18 | 2001 | 1203 | 0.500 |
Why?
|
| Base Sequence | 31 | 2010 | 4917 | 0.500 |
Why?
|
| Endodeoxyribonucleases | 11 | 2001 | 105 | 0.480 |
Why?
|
| DNA Adducts | 7 | 2012 | 210 | 0.480 |
Why?
|
| Saccharomyces cerevisiae Proteins | 8 | 2001 | 445 | 0.480 |
Why?
|
| Genetic Complementation Test | 16 | 2006 | 125 | 0.470 |
Why?
|
| Base Pair Mismatch | 3 | 2016 | 78 | 0.470 |
Why?
|
| HeLa Cells | 25 | 2003 | 1643 | 0.460 |
Why?
|
| DNA, Viral | 10 | 1999 | 694 | 0.460 |
Why?
|
| Mutation | 33 | 2018 | 15179 | 0.450 |
Why?
|
| Bacteriophage lambda | 8 | 1988 | 36 | 0.450 |
Why?
|
| Cell Nucleus | 2 | 2018 | 1620 | 0.450 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 1390 | 0.430 |
Why?
|
| Deoxyribodipyrimidine Photo-Lyase | 3 | 2007 | 6 | 0.430 |
Why?
|
| Amino Acid Sequence | 19 | 2010 | 4233 | 0.420 |
Why?
|
| Cell-Free System | 12 | 2006 | 150 | 0.410 |
Why?
|
| Cell Line | 31 | 2010 | 5114 | 0.410 |
Why?
|
| Humans | 135 | 2021 | 261506 | 0.400 |
Why?
|
| Neoplasms | 7 | 2022 | 15193 | 0.400 |
Why?
|
| Transcription Factor TFIIH | 6 | 2007 | 20 | 0.400 |
Why?
|
| Animals | 58 | 2022 | 59536 | 0.390 |
Why?
|
| Proliferating Cell Nuclear Antigen | 9 | 2006 | 195 | 0.370 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 3 | 2008 | 47 | 0.370 |
Why?
|
| Transcription Factors, TFII | 5 | 2004 | 24 | 0.360 |
Why?
|
| Genes | 6 | 2001 | 491 | 0.350 |
Why?
|
| Mammals | 7 | 2000 | 361 | 0.340 |
Why?
|
| Fungal Proteins | 7 | 2000 | 254 | 0.330 |
Why?
|
| Transcription Factors | 16 | 2007 | 5270 | 0.320 |
Why?
|
| Gene Expression | 5 | 2019 | 3570 | 0.320 |
Why?
|
| Nuclear Proteins | 16 | 2012 | 3343 | 0.320 |
Why?
|
| Vitamin D3 24-Hydroxylase | 4 | 2020 | 22 | 0.320 |
Why?
|
| Blotting, Southern | 2 | 2006 | 406 | 0.310 |
Why?
|
| RNA, Messenger | 5 | 2008 | 6150 | 0.300 |
Why?
|
| Cell Fractionation | 2 | 2006 | 68 | 0.300 |
Why?
|
| Breast Neoplasms | 4 | 2019 | 15694 | 0.300 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2008 | 621 | 0.300 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2010 | 494 | 0.290 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2008 | 196 | 0.280 |
Why?
|
| Radiochemistry | 1 | 2006 | 7 | 0.280 |
Why?
|
| Recombinant Proteins | 14 | 2006 | 2927 | 0.280 |
Why?
|
| Genes, Immunoglobulin | 2 | 2007 | 87 | 0.280 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2006 | 997 | 0.280 |
Why?
|
| Receptors, Calcitriol | 3 | 2020 | 134 | 0.280 |
Why?
|
| Nucleic Acid Conformation | 4 | 2000 | 279 | 0.270 |
Why?
|
| Transcription, Genetic | 11 | 2006 | 3154 | 0.270 |
Why?
|
| Drosophila Proteins | 2 | 2003 | 858 | 0.270 |
Why?
|
| DNA Polymerase III | 4 | 2023 | 31 | 0.270 |
Why?
|
| Deoxyribonuclease (Pyrimidine Dimer) | 3 | 2001 | 12 | 0.270 |
Why?
|
| Recombination, Genetic | 7 | 2008 | 613 | 0.260 |
Why?
|
| Thymus Neoplasms | 1 | 2010 | 400 | 0.250 |
Why?
|
| Chromosomal Instability | 1 | 2006 | 233 | 0.250 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1999 | 261 | 0.250 |
Why?
|
| Protein Structure, Tertiary | 7 | 2010 | 1487 | 0.250 |
Why?
|
| Adenosine Triphosphatases | 3 | 2003 | 435 | 0.250 |
Why?
|
| DNA, Bacterial | 6 | 1993 | 558 | 0.240 |
Why?
|
| Nucleotides | 6 | 2008 | 164 | 0.240 |
Why?
|
| DNA, Single-Stranded | 7 | 2003 | 106 | 0.240 |
Why?
|
| Research | 1 | 2006 | 415 | 0.230 |
Why?
|
| Nucleic Acid Heteroduplexes | 3 | 1997 | 27 | 0.230 |
Why?
|
| DNA Ligases | 5 | 1997 | 63 | 0.230 |
Why?
|
| Cricetinae | 11 | 2001 | 706 | 0.230 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2017 | 787 | 0.220 |
Why?
|
| Replication Protein A | 7 | 2006 | 35 | 0.220 |
Why?
|
| Deoxyribonucleases | 2 | 2001 | 46 | 0.220 |
Why?
|
| DNA Repair Enzymes | 7 | 2003 | 237 | 0.220 |
Why?
|
| Eukaryotic Cells | 2 | 2008 | 45 | 0.210 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2002 | 22 | 0.210 |
Why?
|
| Polymorphism, Genetic | 2 | 2005 | 1450 | 0.210 |
Why?
|
| Iron-Binding Proteins | 1 | 2002 | 35 | 0.210 |
Why?
|
| Writing | 1 | 2023 | 104 | 0.210 |
Why?
|
| Fibroblasts | 7 | 2006 | 1682 | 0.210 |
Why?
|
| Anorectal Malformations | 1 | 2021 | 7 | 0.210 |
Why?
|
| TRPV Cation Channels | 2 | 2020 | 76 | 0.210 |
Why?
|
| Protein Binding | 9 | 2008 | 3438 | 0.210 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 7 | 2004 | 568 | 0.200 |
Why?
|
| Substrate Specificity | 7 | 2010 | 549 | 0.200 |
Why?
|
| Hair Diseases | 2 | 1991 | 43 | 0.200 |
Why?
|
| Lymphoma | 1 | 2010 | 1467 | 0.200 |
Why?
|
| CHO Cells | 7 | 2001 | 311 | 0.200 |
Why?
|
| Calcium Channels | 2 | 2020 | 197 | 0.190 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 10331 | 0.190 |
Why?
|
| Testis | 4 | 2008 | 717 | 0.190 |
Why?
|
| History, 20th Century | 1 | 2023 | 574 | 0.190 |
Why?
|
| Cation Transport Proteins | 1 | 2002 | 199 | 0.190 |
Why?
|
| Genes, Lethal | 1 | 2000 | 120 | 0.190 |
Why?
|
| Steroid Hydroxylases | 3 | 2009 | 36 | 0.190 |
Why?
|
| Mutagenesis | 3 | 1999 | 483 | 0.180 |
Why?
|
| Models, Molecular | 5 | 2016 | 1732 | 0.180 |
Why?
|
| Chromatin | 3 | 2005 | 942 | 0.180 |
Why?
|
| Acetylation | 1 | 2020 | 508 | 0.170 |
Why?
|
| Lymphocytes | 4 | 1999 | 1234 | 0.170 |
Why?
|
| Cells, Cultured | 10 | 2017 | 5637 | 0.170 |
Why?
|
| Models, Genetic | 6 | 2005 | 1113 | 0.160 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2018 | 87 | 0.160 |
Why?
|
| RNA Helicases | 1 | 1999 | 101 | 0.160 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 140 | 0.160 |
Why?
|
| Exercise | 2 | 2017 | 1183 | 0.160 |
Why?
|
| Oligonucleotides | 5 | 2012 | 227 | 0.160 |
Why?
|
| Heart Diseases | 1 | 2004 | 732 | 0.160 |
Why?
|
| Hydroxamic Acids | 1 | 2020 | 442 | 0.160 |
Why?
|
| Telomere-Binding Proteins | 1 | 2018 | 85 | 0.150 |
Why?
|
| Adenosine Triphosphate | 6 | 2001 | 571 | 0.150 |
Why?
|
| Cloning, Molecular | 5 | 2003 | 1213 | 0.150 |
Why?
|
| Mice, Knockout | 4 | 2010 | 5710 | 0.150 |
Why?
|
| Caloric Restriction | 1 | 2017 | 88 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 3 | 2007 | 4367 | 0.150 |
Why?
|
| Catalytic Domain | 2 | 2016 | 303 | 0.150 |
Why?
|
| Amino Acid Motifs | 2 | 2010 | 392 | 0.140 |
Why?
|
| Bacteriophage M13 | 2 | 1993 | 15 | 0.140 |
Why?
|
| Nutritional Status | 1 | 2019 | 337 | 0.140 |
Why?
|
| Ethers, Cyclic | 1 | 1996 | 16 | 0.140 |
Why?
|
| Enzyme Inhibitors | 3 | 2016 | 1879 | 0.140 |
Why?
|
| Pyrans | 1 | 1996 | 20 | 0.140 |
Why?
|
| Mice | 15 | 2010 | 34495 | 0.140 |
Why?
|
| Conserved Sequence | 3 | 2004 | 469 | 0.140 |
Why?
|
| RNA-Binding Proteins | 1 | 2002 | 984 | 0.140 |
Why?
|
| Mammary Glands, Human | 1 | 2017 | 184 | 0.140 |
Why?
|
| Spiro Compounds | 1 | 1996 | 58 | 0.140 |
Why?
|
| Oxidative Stress | 4 | 2017 | 1129 | 0.140 |
Why?
|
| Templates, Genetic | 2 | 2006 | 86 | 0.140 |
Why?
|
| Cytoplasm | 1 | 2018 | 652 | 0.130 |
Why?
|
| Mutagens | 3 | 1999 | 187 | 0.130 |
Why?
|
| Genes, Viral | 5 | 1986 | 202 | 0.130 |
Why?
|
| N-Glycosyl Hydrolases | 4 | 2001 | 47 | 0.130 |
Why?
|
| Gamma Rays | 1 | 2016 | 242 | 0.130 |
Why?
|
| Peptides, Cyclic | 1 | 1996 | 139 | 0.130 |
Why?
|
| Odds Ratio | 2 | 2019 | 2316 | 0.130 |
Why?
|
| Kinetics | 6 | 2012 | 2049 | 0.130 |
Why?
|
| Immunoblotting | 7 | 2005 | 886 | 0.130 |
Why?
|
| alpha-Tocopherol | 2 | 2012 | 78 | 0.130 |
Why?
|
| Calcium, Dietary | 1 | 2014 | 56 | 0.130 |
Why?
|
| Methyltransferases | 1 | 1996 | 148 | 0.120 |
Why?
|
| beta Carotene | 2 | 2012 | 76 | 0.120 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1996 | 214 | 0.120 |
Why?
|
| DNA Primers | 5 | 2005 | 1399 | 0.120 |
Why?
|
| Genomic Instability | 2 | 2023 | 519 | 0.120 |
Why?
|
| DNA Mismatch Repair | 1 | 2016 | 268 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 1498 | 0.120 |
Why?
|
| Lysine | 2 | 2010 | 422 | 0.120 |
Why?
|
| Bone Resorption | 1 | 2014 | 138 | 0.120 |
Why?
|
| Genes, Bacterial | 4 | 1989 | 236 | 0.120 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 316 | 0.120 |
Why?
|
| Exercise Therapy | 1 | 2017 | 288 | 0.120 |
Why?
|
| HEK293 Cells | 1 | 2018 | 1489 | 0.120 |
Why?
|
| Evolution, Molecular | 2 | 2010 | 834 | 0.120 |
Why?
|
| Vascular Resistance | 1 | 2014 | 200 | 0.120 |
Why?
|
| Postpartum Period | 1 | 2014 | 259 | 0.110 |
Why?
|
| Vascular Stiffness | 1 | 2014 | 77 | 0.110 |
Why?
|
| Acetoxyacetylaminofluorene | 1 | 1992 | 1 | 0.110 |
Why?
|
| Molecular Weight | 3 | 2003 | 629 | 0.110 |
Why?
|
| Female | 19 | 2019 | 141928 | 0.110 |
Why?
|
| Cell Survival | 4 | 2009 | 3045 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 6100 | 0.110 |
Why?
|
| Radiation Tolerance | 3 | 2009 | 629 | 0.110 |
Why?
|
| Binding Sites | 6 | 2005 | 2171 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 8873 | 0.110 |
Why?
|
| Genome, Human | 1 | 2001 | 1869 | 0.110 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2007 | 311 | 0.110 |
Why?
|
| Testicular Neoplasms | 3 | 2008 | 529 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 5539 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2018 | 2084 | 0.100 |
Why?
|
| Terminology as Topic | 1 | 1994 | 414 | 0.100 |
Why?
|
| Ferritins | 3 | 2012 | 151 | 0.100 |
Why?
|
| C-Reactive Protein | 2 | 2006 | 527 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 1538 | 0.100 |
Why?
|
| Retinoid X Receptor alpha | 2 | 2009 | 42 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2017 | 1467 | 0.100 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 11538 | 0.100 |
Why?
|
| Antibody Specificity | 2 | 2009 | 334 | 0.090 |
Why?
|
| Macromolecular Substances | 3 | 2000 | 293 | 0.090 |
Why?
|
| Sequence Alignment | 2 | 2003 | 844 | 0.090 |
Why?
|
| Oligonucleotide Probes | 2 | 2006 | 130 | 0.090 |
Why?
|
| Lyases | 1 | 1989 | 10 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 526 | 0.090 |
Why?
|
| Reticulocytes | 1 | 2009 | 55 | 0.090 |
Why?
|
| DNA Polymerase II | 4 | 2000 | 59 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 5319 | 0.090 |
Why?
|
| Fanconi Anemia | 2 | 2005 | 88 | 0.090 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2009 | 34 | 0.090 |
Why?
|
| Bacterial Proteins | 3 | 2000 | 1029 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 2045 | 0.090 |
Why?
|
| Incidence | 1 | 2019 | 5673 | 0.090 |
Why?
|
| Simian virus 40 | 1 | 1989 | 137 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 4320 | 0.080 |
Why?
|
| Dimerization | 3 | 2008 | 304 | 0.080 |
Why?
|
| Whole-Body Irradiation | 1 | 2009 | 307 | 0.080 |
Why?
|
| Adenoma | 2 | 2011 | 716 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2010 | 5159 | 0.080 |
Why?
|
| Tyrosine | 1 | 2010 | 498 | 0.080 |
Why?
|
| Colorectal Neoplasms | 3 | 2011 | 3578 | 0.080 |
Why?
|
| Male | 17 | 2019 | 123000 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 259 | 0.080 |
Why?
|
| Microinjections | 3 | 1998 | 96 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 703 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 191 | 0.080 |
Why?
|
| Lactams, Macrocyclic | 1 | 2008 | 90 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 280 | 0.080 |
Why?
|
| Benzoquinones | 1 | 2008 | 108 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2001 | 1555 | 0.080 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 3 | 1997 | 14 | 0.080 |
Why?
|
| Gene Library | 2 | 2001 | 294 | 0.080 |
Why?
|
| Drug Stability | 1 | 2007 | 105 | 0.080 |
Why?
|
| Quality of Life | 1 | 2021 | 4532 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2018 | 14551 | 0.070 |
Why?
|
| Inflammation | 1 | 2017 | 2522 | 0.070 |
Why?
|
| Genes, p53 | 2 | 2006 | 1090 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2008 | 3203 | 0.070 |
Why?
|
| Avian Proteins | 1 | 2006 | 27 | 0.070 |
Why?
|
| DNA Polymerase beta | 1 | 2006 | 19 | 0.070 |
Why?
|
| Chromosomes, Bacterial | 1 | 1987 | 62 | 0.070 |
Why?
|
| Precipitin Tests | 3 | 2004 | 329 | 0.070 |
Why?
|
| Rodentia | 3 | 1996 | 65 | 0.070 |
Why?
|
| Base Pairing | 3 | 2006 | 68 | 0.070 |
Why?
|
| Cytosine Deaminase | 1 | 2005 | 39 | 0.070 |
Why?
|
| Homeostasis | 1 | 2011 | 950 | 0.070 |
Why?
|
| Drug Resistance | 2 | 1995 | 587 | 0.070 |
Why?
|
| In Vitro Techniques | 5 | 2006 | 1618 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2001 | 987 | 0.070 |
Why?
|
| Oxygen Consumption | 2 | 2017 | 401 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2004 | 889 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 342 | 0.070 |
Why?
|
| RNA | 1 | 1990 | 1013 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 943 | 0.060 |
Why?
|
| Cyclins | 2 | 1998 | 456 | 0.060 |
Why?
|
| Restriction Mapping | 2 | 1999 | 264 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 848 | 0.060 |
Why?
|
| Hydroxyl Radical | 1 | 2004 | 19 | 0.060 |
Why?
|
| Receptors, Transferrin | 1 | 2004 | 45 | 0.060 |
Why?
|
| Iron, Dietary | 1 | 2004 | 19 | 0.060 |
Why?
|
| Europe | 1 | 2006 | 649 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2884 | 0.060 |
Why?
|
| Tretinoin | 1 | 2007 | 623 | 0.060 |
Why?
|
| Chromosomes, Human | 1 | 2005 | 295 | 0.060 |
Why?
|
| Time Factors | 5 | 2017 | 12926 | 0.060 |
Why?
|
| Cell Transformation, Viral | 3 | 2004 | 138 | 0.060 |
Why?
|
| Superoxides | 1 | 2004 | 211 | 0.060 |
Why?
|
| Adenine | 1 | 2007 | 631 | 0.060 |
Why?
|
| Infant | 1 | 2019 | 13310 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 4053 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 2 | 2017 | 602 | 0.060 |
Why?
|
| Alleles | 1 | 2010 | 2437 | 0.060 |
Why?
|
| Child | 3 | 2021 | 29154 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2005 | 4938 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 1058 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2019 | 16273 | 0.060 |
Why?
|
| DNA Glycosylases | 2 | 2001 | 93 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 837 | 0.050 |
Why?
|
| Interleukin-6 | 2 | 2017 | 1038 | 0.050 |
Why?
|
| Placebos | 2 | 2014 | 437 | 0.050 |
Why?
|
| Mass Screening | 1 | 2011 | 1509 | 0.050 |
Why?
|
| Peptides | 3 | 2014 | 1479 | 0.050 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2002 | 11 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 741 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 717 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2010 | 3552 | 0.050 |
Why?
|
| Multienzyme Complexes | 2 | 1996 | 213 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 3639 | 0.050 |
Why?
|
| Antibody Diversity | 1 | 2001 | 8 | 0.050 |
Why?
|
| Drosophila melanogaster | 2 | 2001 | 829 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 4143 | 0.050 |
Why?
|
| Chromatography, Gel | 1 | 2001 | 157 | 0.050 |
Why?
|
| Protein Conformation | 3 | 2006 | 1258 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 803 | 0.050 |
Why?
|
| Cloaca | 1 | 2021 | 16 | 0.050 |
Why?
|
| Models, Immunological | 1 | 2001 | 77 | 0.050 |
Why?
|
| Exonucleases | 1 | 2001 | 51 | 0.050 |
Why?
|
| Insecta | 1 | 2001 | 76 | 0.050 |
Why?
|
| Antibodies | 3 | 1997 | 838 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2001 | 108 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 2216 | 0.050 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 2 | 2000 | 69 | 0.050 |
Why?
|
| Thermoproteaceae | 1 | 2001 | 1 | 0.050 |
Why?
|
| Transcription Factor TFIID | 1 | 2001 | 26 | 0.050 |
Why?
|
| United States | 1 | 2019 | 15433 | 0.050 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2001 | 26 | 0.050 |
Why?
|
| Chromosome Mapping | 2 | 2003 | 1471 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1992 | 82 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2001 | 250 | 0.050 |
Why?
|
| Methionine | 1 | 2001 | 159 | 0.050 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2001 | 173 | 0.050 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 1991 | 97 | 0.050 |
Why?
|
| Antineoplastic Agents | 5 | 2009 | 14289 | 0.050 |
Why?
|
| Ficusin | 1 | 2000 | 13 | 0.050 |
Why?
|
| Dose-Response Relationship, Radiation | 4 | 2009 | 726 | 0.050 |
Why?
|
| Dysplastic Nevus Syndrome | 2 | 1991 | 50 | 0.050 |
Why?
|
| Rad51 Recombinase | 1 | 2001 | 126 | 0.050 |
Why?
|
| Anal Canal | 1 | 2021 | 238 | 0.050 |
Why?
|
| Nucleotidyltransferases | 2 | 2012 | 82 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2000 | 300 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2001 | 869 | 0.050 |
Why?
|
| Cricetulus | 4 | 1994 | 205 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 2006 | 1245 | 0.050 |
Why?
|
| Purine Nucleosides | 1 | 2000 | 48 | 0.050 |
Why?
|
| Thermodynamics | 1 | 2000 | 196 | 0.050 |
Why?
|
| Transferrin | 2 | 2012 | 78 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2004 | 764 | 0.050 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2000 | 45 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2004 | 785 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2001 | 274 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2012 | 2278 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 5395 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2000 | 1764 | 0.040 |
Why?
|
| Sodium Chloride | 2 | 2001 | 156 | 0.040 |
Why?
|
| Archaea | 1 | 1999 | 18 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1999 | 124 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 1 | 1999 | 70 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 1999 | 128 | 0.040 |
Why?
|
| Tissue Extracts | 1 | 1999 | 48 | 0.040 |
Why?
|
| 2-Acetylaminofluorene | 2 | 1989 | 11 | 0.040 |
Why?
|
| Adolescent | 1 | 2019 | 31252 | 0.040 |
Why?
|
| Germinoma | 1 | 1999 | 84 | 0.040 |
Why?
|
| Biomarkers | 2 | 2014 | 5047 | 0.040 |
Why?
|
| Models, Chemical | 1 | 1999 | 186 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2017 | 32848 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1999 | 324 | 0.040 |
Why?
|
| Carcinogens | 2 | 2007 | 384 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2008 | 11965 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2014 | 2588 | 0.040 |
Why?
|
| F2-Isoprostanes | 1 | 2017 | 28 | 0.040 |
Why?
|
| Exodeoxyribonucleases | 2 | 1995 | 104 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 2508 | 0.040 |
Why?
|
| Creatinine | 2 | 2017 | 531 | 0.040 |
Why?
|
| Axin Protein | 1 | 2017 | 27 | 0.040 |
Why?
|
| Middle Aged | 9 | 2017 | 86204 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2021 | 739 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 1997 | 34 | 0.040 |
Why?
|
| Intercalating Agents | 1 | 1997 | 29 | 0.040 |
Why?
|
| Albuminuria | 1 | 2017 | 113 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 1998 | 205 | 0.040 |
Why?
|
| Antibodies, Blocking | 1 | 2017 | 91 | 0.040 |
Why?
|
| Massachusetts | 1 | 2017 | 106 | 0.040 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 1997 | 109 | 0.040 |
Why?
|
| Physical Endurance | 1 | 2017 | 58 | 0.040 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 52 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2019 | 37905 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2002 | 2074 | 0.040 |
Why?
|
| Microcystins | 1 | 1996 | 2 | 0.040 |
Why?
|
| Marine Toxins | 1 | 1996 | 12 | 0.040 |
Why?
|
| Okadaic Acid | 1 | 1996 | 28 | 0.040 |
Why?
|
| Interphase | 1 | 1995 | 145 | 0.030 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 1996 | 69 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 300 | 0.030 |
Why?
|
| Adiposity | 1 | 2017 | 237 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2004 | 2283 | 0.030 |
Why?
|
| Leukemia L1210 | 1 | 1995 | 54 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 2 | 1989 | 966 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 4638 | 0.030 |
Why?
|
| RNA Interference | 2 | 2010 | 1408 | 0.030 |
Why?
|
| Hypotension | 1 | 2017 | 210 | 0.030 |
Why?
|
| Chromatography | 1 | 1994 | 49 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 1991 | 4654 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2017 | 576 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1994 | 82 | 0.030 |
Why?
|
| Durapatite | 1 | 1994 | 31 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2000 | 1688 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 1994 | 122 | 0.030 |
Why?
|
| Point Mutation | 1 | 1997 | 769 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1994 | 68 | 0.030 |
Why?
|
| Baculoviridae | 1 | 1994 | 86 | 0.030 |
Why?
|
| Moths | 1 | 1994 | 36 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 330 | 0.030 |
Why?
|
| Transfection | 3 | 2006 | 2944 | 0.030 |
Why?
|
| Viral Structural Proteins | 1 | 1994 | 47 | 0.030 |
Why?
|
| Walking | 1 | 2017 | 277 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 239 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 430 | 0.030 |
Why?
|
| Mexico | 1 | 2014 | 259 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2014 | 207 | 0.030 |
Why?
|
| Calcium | 2 | 2009 | 1537 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 5767 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1994 | 141 | 0.030 |
Why?
|
| Ethylnitrosourea | 1 | 1993 | 19 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2014 | 204 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 15862 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 650 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2001 | 2218 | 0.030 |
Why?
|
| Aged | 6 | 2017 | 70117 | 0.030 |
Why?
|
| Thymine Nucleotides | 1 | 1993 | 17 | 0.030 |
Why?
|
| Uridine Triphosphate | 1 | 1993 | 19 | 0.030 |
Why?
|
| Biotin | 1 | 1993 | 69 | 0.030 |
Why?
|
| beta Catenin | 1 | 2017 | 688 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1993 | 185 | 0.030 |
Why?
|
| Finland | 1 | 2012 | 55 | 0.030 |
Why?
|
| Aphidicolin | 1 | 1992 | 30 | 0.030 |
Why?
|
| Electrophoresis | 1 | 1992 | 60 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1993 | 218 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 1293 | 0.030 |
Why?
|
| Skin | 1 | 1998 | 1259 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 81 | 0.030 |
Why?
|
| Sulfur | 1 | 1991 | 16 | 0.030 |
Why?
|
| Autoradiography | 1 | 1991 | 132 | 0.030 |
Why?
|
| Sigmoidoscopy | 1 | 2011 | 47 | 0.030 |
Why?
|
| Viral Proteins | 1 | 1994 | 435 | 0.030 |
Why?
|
| Models, Biological | 2 | 2008 | 3254 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2014 | 619 | 0.020 |
Why?
|
| Genes, pol | 1 | 2010 | 8 | 0.020 |
Why?
|
| Meat | 1 | 2011 | 87 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 548 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 2803 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1991 | 281 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 1991 | 342 | 0.020 |
Why?
|
| France | 1 | 2010 | 108 | 0.020 |
Why?
|
| Pyrimidines | 3 | 2008 | 3518 | 0.020 |
Why?
|
| Trioxsalen | 1 | 1989 | 5 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2017 | 7226 | 0.020 |
Why?
|
| Cattle | 1 | 1991 | 783 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 2004 | 394 | 0.020 |
Why?
|
| United Kingdom | 1 | 2010 | 257 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 1996 | 834 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1995 | 1265 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1989 | 110 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 1995 | 1143 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 1992 | 212 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 1991 | 512 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2009 | 36 | 0.020 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2009 | 44 | 0.020 |
Why?
|
| Ovary | 3 | 1984 | 668 | 0.020 |
Why?
|
| DNA, Superhelical | 1 | 1989 | 23 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 189 | 0.020 |
Why?
|
| Oxygen | 1 | 1993 | 754 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2009 | 226 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1995 | 1493 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2009 | 160 | 0.020 |
Why?
|
| Free Radicals | 2 | 2001 | 62 | 0.020 |
Why?
|
| Cyclin E | 1 | 2010 | 267 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 1863 | 0.020 |
Why?
|
| Crossing Over, Genetic | 1 | 2008 | 56 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 699 | 0.020 |
Why?
|
| Kidney | 1 | 2017 | 2146 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2007 | 7222 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1989 | 621 | 0.020 |
Why?
|
| Phosphorylation | 1 | 1996 | 4804 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2007 | 33 | 0.020 |
Why?
|
| Lysogeny | 1 | 1987 | 10 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2009 | 423 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2007 | 50 | 0.020 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2007 | 51 | 0.020 |
Why?
|
| Base Composition | 1 | 1987 | 92 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 6942 | 0.020 |
Why?
|
| Retinoid X Receptors | 1 | 2007 | 85 | 0.020 |
Why?
|
| Risk Factors | 3 | 2012 | 17523 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 1995 | 1664 | 0.020 |
Why?
|
| Adult | 5 | 2017 | 77950 | 0.020 |
Why?
|
| Rec A Recombinases | 1 | 1986 | 29 | 0.020 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2006 | 32 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 2819 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 2864 | 0.020 |
Why?
|
| Chickens | 1 | 2006 | 523 | 0.020 |
Why?
|
| Xenopus | 2 | 1997 | 219 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 217 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1991 | 3536 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 1998 | 528 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 212 | 0.020 |
Why?
|
| Flap Endonucleases | 2 | 1995 | 26 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2009 | 1014 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2004 | 189 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2004 | 66 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 2483 | 0.020 |
Why?
|
| Viral Plaque Assay | 1 | 1984 | 48 | 0.020 |
Why?
|
| Pregnancy | 2 | 2014 | 7573 | 0.020 |
Why?
|
| Lentivirus | 1 | 2004 | 169 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2004 | 220 | 0.010 |
Why?
|
| Anticarcinogenic Agents | 1 | 2006 | 362 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 2450 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 1991 | 1032 | 0.010 |
Why?
|
| Longevity | 1 | 2004 | 154 | 0.010 |
Why?
|
| Imidazoles | 1 | 2009 | 999 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 4109 | 0.010 |
Why?
|
| Sunlight | 1 | 1983 | 79 | 0.010 |
Why?
|
| X-Rays | 1 | 1983 | 146 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2011 | 1423 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 769 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 3101 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2004 | 584 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2006 | 1442 | 0.010 |
Why?
|
| Carbon-Oxygen Lyases | 1 | 2001 | 14 | 0.010 |
Why?
|
| Deoxyribonuclease IV (Phage T4-Induced) | 1 | 2001 | 15 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 2315 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 2001 | 121 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 1294 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1986 | 1005 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 2001 | 105 | 0.010 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2001 | 66 | 0.010 |
Why?
|
| Potassium Permanganate | 1 | 2000 | 3 | 0.010 |
Why?
|
| Peanut Agglutinin | 1 | 2000 | 5 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2001 | 515 | 0.010 |
Why?
|
| Ouabain | 1 | 1980 | 40 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6207 | 0.010 |
Why?
|
| Biopolymers | 1 | 2000 | 38 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2006 | 808 | 0.010 |
Why?
|
| Thioguanine | 1 | 1980 | 68 | 0.010 |
Why?
|
| Diphtheria Toxin | 1 | 1980 | 81 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2000 | 227 | 0.010 |
Why?
|
| Temperature | 1 | 2001 | 506 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 4549 | 0.010 |
Why?
|
| Germinal Center | 1 | 2000 | 161 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 1998 | 43 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 14889 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 3441 | 0.010 |
Why?
|
| Uracil | 1 | 1999 | 64 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 611 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 4298 | 0.010 |
Why?
|
| Phylogeny | 1 | 2001 | 826 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 7548 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 2203 | 0.010 |
Why?
|
| Immunization | 1 | 2000 | 397 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2007 | 2359 | 0.010 |
Why?
|
| Cell Separation | 1 | 2000 | 612 | 0.010 |
Why?
|
| Spleen | 1 | 2000 | 676 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1997 | 201 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 9244 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1997 | 234 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 4078 | 0.010 |
Why?
|
| Bacteriophage T4 | 1 | 1995 | 7 | 0.010 |
Why?
|
| Replication Protein C | 1 | 1995 | 18 | 0.010 |
Why?
|
| DNA Ligase ATP | 1 | 1995 | 51 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2000 | 2314 | 0.010 |
Why?
|
| Ovum | 1 | 1994 | 54 | 0.010 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 1995 | 110 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1994 | 128 | 0.010 |
Why?
|
| Schizosaccharomyces | 1 | 1994 | 116 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 3869 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2004 | 5112 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2006 | 5687 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1994 | 200 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2006 | 6869 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1998 | 1271 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 21713 | 0.010 |
Why?
|
| Drosophila | 1 | 1997 | 839 | 0.010 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1992 | 124 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1992 | 194 | 0.010 |
Why?
|
| Methoxsalen | 1 | 1990 | 6 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2006 | 12873 | 0.010 |
Why?
|
| Sodium | 1 | 1992 | 353 | 0.010 |
Why?
|
| Reference Values | 1 | 1992 | 1099 | 0.010 |
Why?
|
| Platinum | 1 | 1990 | 138 | 0.010 |
Why?
|
| Biological Assay | 1 | 1990 | 177 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1994 | 2232 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1984 | 57 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1994 | 4757 | 0.000 |
Why?
|